angiotensin ii has been researched along with am 251 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bátkai, S; Bukoski, RD; Harvey-White, J; Kunos, G; Liu, J; Mackie, K; Offertáler, L; Osei-Hyiaman, D; Pacher, P; Radaeva, S; Rudd, MA | 1 |
| Fujihara, H; Hashimoto, H; Nagatomo, T; Ohbuchi, T; Otsubo, H; Saito, T; Suzuki, H; Ueta, Y; Yokoyama, T | 1 |
| Bagdy, G; Catt, KJ; Gyombolai, P; Hunyady, L; Pap, D; Turu, G | 1 |
| Balla, A; Catt, KJ; Hunyady, L; Nádasy, GL; Soltész-Katona, E; Szekeres, M; Tóth, ZE; Turu, G | 1 |
| Gyires, K; Hunyady, L; Németh, J; Rónai, AZ; Szekeres, M; Tóth, VE; Zádori, ZS | 1 |
1 review(s) available for angiotensin ii and am 251
| Article | Year |
|---|---|
Regulation of endocannabinoid release by G proteins: a paracrine mechanism of G protein-coupled receptor action.
Topics: Angiotensin II; Animals; Arachidonic Acids; Cannabinoid Receptor Modulators; Endocannabinoids; Glycerides; GTP-Binding Protein alpha Subunits, Gq-G11; Humans; Paracrine Communication; Paraventricular Hypothalamic Nucleus; Piperidines; Pyrazoles; Rats; Receptor, Angiotensin, Type 1; Receptor, Cannabinoid, CB1 | 2012 |
4 other study(ies) available for angiotensin ii and am 251
| Article | Year |
|---|---|
Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.
Topics: Amidohydrolases; Angiotensin II; Animals; Arachidonic Acids; Benzamides; Benzyl Compounds; Blood Pressure; Camphanes; Carbamates; Dronabinol; Endocannabinoids; Endothelium, Vascular; Hypertension; Male; Models, Cardiovascular; Myocardial Contraction; Myocardium; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Inbred Dahl; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Up-Regulation; Vascular Resistance; Vasodilation; Ventricular Function, Left | 2004 |
TRPV1 gene deficiency attenuates miniature EPSC potentiation induced by mannitol and angiotensin II in supraoptic magnocellular neurons.
Topics: Analysis of Variance; Angiotensin II; Anilides; Animals; Capsaicin; Chelating Agents; Cinnamates; Diuretics, Osmotic; Drug Interactions; Egtazic Acid; Enzyme Inhibitors; In Vitro Techniques; Male; Mannitol; Mice; Mice, Inbred C57BL; Mice, Knockout; Miniature Postsynaptic Potentials; Neurons; Piperidines; Pyrazines; Pyrazoles; Pyridines; Rats; Rats, Wistar; Signal Transduction; Supraoptic Nucleus; TRPV Cation Channels; Vasoconstrictor Agents | 2010 |
Angiotensin II induces vascular endocannabinoid release, which attenuates its vasoconstrictor effect via CB1 cannabinoid receptors.
Topics: Analgesics; Angiotensin II; Animals; Arteries; Benzoxazines; Endocannabinoids; Endothelium, Vascular; Hypertension; Male; Mice; Mice, Knockout; Morpholines; Muscle, Skeletal; Naphthalenes; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Vasoconstriction | 2012 |
Angiotensin II-induced activation of central AT1 receptors exerts endocannabinoid-mediated gastroprotective effect in rats.
Topics: Angiotensin II; Animals; Atropine; CHO Cells; Cricetulus; Ethanol; Gastric Mucosa; Gene Expression Regulation; Injections, Intraventricular; Lactones; Lipoprotein Lipase; Male; Mice; Mice, Knockout; Orlistat; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Cannabinoid, CB1; Signal Transduction; Stomach; Stomach Ulcer; Vagotomy; Vagus Nerve | 2014 |